Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 606
5
Diseases
2
Unique genes
0.405
Avg. similarity score
Circumferential skin creases kunze type
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Circumferential skin creases kunze type
Developmental disorder with cleft palate, cranial malformations and circumferential skin creases (kunze type)
Skin creases, congenital symmetric circumferential, 1
Skin creases, congenital symmetric circumferential, 2
Symmetric circumferential skin creases, congenital, 2
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Circumferential skin creases kunze type | 4 | 4 | 2 |
| Developmental disorder with cleft palate, cranial malformations and circumferential skin creases (kunze type) | 3 | 3 | 1 |
| Skin creases, congenital symmetric circumferential, 1 | 3 | 3 | 1 |
| Skin creases, congenital symmetric circumferential, 2 | 3 | 3 | 1 |
| Symmetric circumferential skin creases, congenital, 2 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TUBB | 4 / 5 | Circumferential skin creases kunze type, Developmental disorder with cleft palate, cranial malformations and circumferential skin creases (kunze type), Skin creases, congenital symmetric circumferential, 1, Skin creases, congenital symmetric circumferential, 2 |
| MAPRE2 | 2 / 5 | Circumferential skin creases kunze type, Symmetric circumferential skin creases, congenital, 2 |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
None of these pathways reaches significance (all FDR q ≥ 0.05). They’re the best candidates found, but treat them as weak evidence for why this cluster groups together.
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Loss of Nlp from mitotic centrosomes | Reactome | 1 / 70 | 85.8× | 1.16e-2 | 6.22e-2 |
| Loss of proteins required for interphase microtubule organization from the centrosome | Reactome | 1 / 70 | 85.8× | 1.16e-2 | 6.22e-2 |
| AURKA Activation by TPX2 | Reactome | 1 / 73 | 82.3× | 1.21e-2 | 6.40e-2 |
| Recruitment of mitotic centrosome proteins and complexes | Reactome | 1 / 82 | 73.2× | 1.36e-2 | 6.86e-2 |
| Regulation of PLK1 Activity at G2/M Transition | Reactome | 1 / 88 | 68.2× | 1.46e-2 | 7.14e-2 |
| Gap junction | KEGG | 1 / 89 | 67.5× | 1.48e-2 | 7.21e-2 |
| Recruitment of NuMA to mitotic centrosomes | Reactome | 1 / 94 | 63.9× | 1.56e-2 | 7.44e-2 |
| Anchoring of the basal body to the plasma membrane | Reactome | 1 / 98 | 61.3× | 1.63e-2 | 7.61e-2 |
| Phagosome | KEGG | 1 / 155 | 38.7× | 2.56e-2 | 9.90e-2 |
| Motor proteins | KEGG | 1 / 194 | 31.0× | 3.20e-2 | 1.12e-1 |
| Pathogenic Escherichia coli infection | KEGG | 1 / 200 | 30.0× | 3.30e-2 | 1.14e-1 |
| Salmonella infection | KEGG | 1 / 248 | 24.2× | 4.09e-2 | 1.29e-1 |
| Parkinson disease | KEGG | 1 / 268 | 22.4× | 4.41e-2 | 1.35e-1 |
| Prion disease | KEGG | 1 / 275 | 21.8× | 4.53e-2 | 1.37e-1 |
| Huntington disease | KEGG | 1 / 308 | 19.5× | 5.06e-2 | 1.46e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| spindle assembly | GO:0051225 | 2 / 40 | 467× | 4.47e-6 | 2.89e-4 ✓ sig. |
| positive regulation of ARF protein signal transduction | GO:0032014 | 1 / 2 | 4,672× | 2.14e-4 | 5.31e-3 ✓ sig. |
| cell division | GO:0051301 | 2 / 406 | 46.0× | 4.71e-4 | 9.15e-3 ✓ sig. |
| odontoblast differentiation | GO:0071895 | 1 / 8 | 1,168× | 8.56e-4 | 1.33e-2 ✓ sig. |
| positive regulation of focal adhesion disassembly | GO:0120183 | 1 / 8 | 1,168× | 8.56e-4 | 1.33e-2 ✓ sig. |
| protein localization to microtubule | GO:0035372 | 1 / 10 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| positive regulation of keratinocyte migration | GO:0051549 | 1 / 12 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| cytoskeleton-dependent intracellular transport | GO:0030705 | 1 / 14 | 667× | 1.50e-3 | 1.82e-2 ✓ sig. |
| regulation of microtubule polymerization or depolymerization | GO:0031110 | 1 / 15 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |
| regulation of synapse organization | GO:0050807 | 1 / 30 | 311× | 3.21e-3 | 2.69e-2 ✓ sig. |
| natural killer cell mediated cytotoxicity | GO:0042267 | 1 / 41 | 228× | 4.38e-3 | 3.14e-2 ✓ sig. |
| microtubule-based process | GO:0007017 | 1 / 46 | 203× | 4.92e-3 | 3.31e-2 ✓ sig. |
| mitotic cell cycle | GO:0000278 | 1 / 142 | 65.8× | 1.51e-2 | 5.68e-2 |
| microtubule cytoskeleton organization | GO:0000226 | 1 / 149 | 62.7× | 1.59e-2 | 5.83e-2 |